Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on rare diseases, will host a conference call and audio webcast on Thursday, July 31, 2025, at 8:30 a.m. ET to discuss its second quarter 2025 financial results.

Participants must pre-register online to receive dial-in details and a personal PIN for the call. A live webcast and presentation materials will be available through the Investors section at ir.amicusrx.com, with web participants encouraged to register 15 minutes before the call. An archived version of the webcast and slides will be available after the event.

PRINCETON, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, July 31, 2025, at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2025.

Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.

An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Vice President, Corporate Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When is Amicus Therapeutics (FOLD) Q2 2025 earnings call?

Amicus Therapeutics will host its Q2 2025 earnings call on Thursday, July 31, 2025, at 8:30 a.m. ET.

How can investors join the Amicus Therapeutics Q2 2025 earnings call?

Investors must first register through the online registration form to receive a dial-in number and personal PIN. Alternatively, they can access the live webcast through ir.amicusrx.com.

What period will Amicus Therapeutics Q2 2025 results cover?

The earnings results will cover the second quarter ended June 30, 2025.

Where can I find the replay of Amicus Therapeutics Q2 2025 earnings call?

An archived webcast and accompanying slides will be available on the company's website at ir.amicusrx.com shortly after the live event.